What is the Effect of High-Intensity Training on Diabetes and Cardiovascular Disease in Menopause?
BACKGROUND AND PURPOSE:
While menopause is associated with an increased risk of cardiovascular disease, the exact causes are not fully understood.
Loss of estrogen and other hormonal changes could play a role
Menopause is also associated with increased fat mass
This study by Mandrup et al. (AJOG, 2017) aimed to estimate risk factors for type II diabetes and cardiovascular disease among late premenopausal and early postmenopausal women, and the effect of high-intensity training.
Matched Interventional Study
79 non-obese women took part in 3 months of high-intensity aerobic training
40 women were late premenopausal
39 women were early postmenopausal
Anthropometrics, body composition, blood pressure, lipid profile, glucose tolerance, and maximal oxygen consumption were measured before and after the training
Matched for anthropometrics and body composition
Time since last menstrual period was 3.1 years (95% CI 2.6-3.7)
Mean age of postmenopausal group was 53.4 vs. 49.2 years
Premenopausal and postmenopausal women had similar baseline cardiovascular risk factors except:
Postmenopausal women had higher total cholesterol at baseline (P<.001)
Postmenopausal had higher low-density lipoprotein (P<.05) and high-density lipoprotein (P<.001)
In both groups training reduced body weight (P<.01), waist circumference (P<.01), increased lean body mass (P<.001), and decreased fat mass (P<.001)
Follow training, both groups had lower diastolic blood pressure (P<.05), resting heart rate (P<.001),
Both groups saw decreases in total cholesterol (P<.01), low-density lipoprotein-cholesterol (P<.01), total cholesterol/high-density lipoprotein-cholesterol index (P<.01), and improved plasma insulin concentration following training (P<.05)
3 months of high-intensity aerobic training reduces risk factors for type II diabetes and cardiovascular disease similarly in late premenopausal and early postmenopausal women.
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan